The mechanisms that contribute to homeostasis of the immune system in sepsis are largely unknown. One study suggests a potential detrimental role for thymic stromal lymphopoietin (TSLP) in sepsis; however, the immune-regulatory effects of TSLP on myeloid cells within the intestinal microenvironment suggest the contrary. Our objective was to clarify TSLP's role in sepsis. Cecal ligation and puncture was performed in mice with total or myeloid-specific deficiency in the TSLP receptor (TSLPR). Survival was monitored closely, peritoneal fluids and plasma were analyzed for markers of inflammation, and myeloid cell numbers and their ability to produce inflammatory mediators was determined. The interaction of TSLP with TSLPR in myeloid cells contributed to mouse survival after septic peritonitis. Mice with TSLPR deficiency in myeloid cells displayed excessive local and systemic inflammation levels (e.g., increased inflammatory cell and cytokine levels) relative to control mice. Moreover, hepatic injury was exacerbated in mice with TSLPR deficiency in their myeloid cells. However, the enhanced inflammatory response did not affect the ability of these mice to clear bacteria. Resident neutrophils and macrophages from septic mice with TSLPR deficiency exhibited an increased ability to produce proinflammatory cytokines. Collectively, our findings suggest that the effects of TSLP on myeloid cells are crucial in reducing the multiple organ failure that is associated with systemic inflammation, which highlights the significance of this cytokine in modulating the host response to infection and in reducing the risks of sepsis development.Keywords: sepsis; inflammation; myeloid cells; thymic stromal lymphopoietin
Clinical RelevanceInfections can lead to sepsis, a complex, incompletely understood, and often fatal disorder that is considered to reflect dysregulation of the host immune response. Early diagnosis and treatment of sepsis is critical to prevent the cascade of the complex processes that lead to severe sepsis and septic shock. However, the best available diagnostic and treatment strategies have failed, which underscores the need for a better understanding of the pathophysiological mechanisms regulating the inflammatory host response during sepsis. Our study provides evidence that thymic stromal lymphopoietin is part of a mechanism that is initiated by the host to restore homeostasis during the inflammatory response against bacterial infections to reduce the risk of sepsis development.